Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
GASTRITIS
Interventions
DRUG

Levofloxacin

The primary objective was to evaluate the efficacy of the 10-day course of levofloxacin, doxycycline and esomeprazole in non-responders to first-line therapies for H. pylori eradication in Saudi Arabia. Secondary objectives included; symptoms response to treatment, factors associated with eradication of H. pylori and adverse events associated with the treatment

DRUG

Doxycycline

The primary objective was to evaluate the efficacy of the 10-day course of levofloxacin, doxycycline and esomeprazole in non-responders to first-line therapies for H. pylori eradication in Saudi Arabia. Secondary objectives included; symptoms response to treatment, factors associated with eradication of H. pylori and adverse events associated with the treatment

DRUG

Esomeprazole

The primary objective was to evaluate the efficacy of the 10-day course of levofloxacin, doxycycline and esomeprazole in non-responders to first-line therapies for H. pylori eradication in Saudi Arabia. Secondary objectives included; symptoms response to treatment, factors associated with eradication of H. pylori and adverse events associated with the treatment

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT02884713 - Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia | Biotech Hunter | Biotech Hunter